Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Choice of first-line therapy in metastatic melanoma.

× No keyword cloud information.

5 in total

1. Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients.

Authors: Paweł Rogala; Anna M Czarnecka; Bożena Cybulska-Stopa; Krzysztof Ostaszewski; Karolina Piejko; Marcin Ziętek; Robert Dziura; Ewa Rutkowska; Łukasz Galus; Natasza Kempa-Kamińska; Joanna Seredyńska; Wiesław Bal; Katarzyna Kozak; Anna Surus-Hyla; Tomasz Kubiatowski; Grażyna Kamińska-Winciorek; Rafał Suwiński; Jacek Mackiewicz; Piotr Rutkowski
Journal: Cancers (Basel) Date: 2022-04-24 Impact factor: 6.575

Review 2. Targeting cell cycle regulation via the G2-M checkpoint for synthetic lethality in melanoma.

Authors: Nicholas Barnaba; Jeannine R LaRocque
Journal: Cell Cycle Date: 2021-05-09 Impact factor: 4.534

3. Intertumoral Genetic Heterogeneity Generates Distinct Tumor Microenvironments in a Novel Murine Synchronous Melanoma Model.

Authors: Shuyang S Qin; Booyeon J Han; Alyssa Williams; Katherine M Jackson; Rachel Jewell; Alexander C Chacon; Edith M Lord; David C Linehan; Minsoo Kim; Alexandre Reuben; Scott A Gerber; Peter A Prieto
Journal: Cancers (Basel) Date: 2021-05-11 Impact factor: 6.639

4. Triple Combination Therapy With PD-1/PD-L1, BRAF, and MEK Inhibitor for Stage III-IV Melanoma: A Systematic Review and Meta-Analysis.

Authors: Ye Liu; Xilan Zhang; Guoying Wang; Xinchang Cui
Journal: Front Oncol Date: 2021-06-14 Impact factor: 6.244

Review 5. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.

Authors: Fabienne Maibach; Hassan Sadozai; S Morteza Seyed Jafari; Robert E Hunger; Mirjam Schenk
Journal: Front Immunol Date: 2020-09-10 Impact factor: 7.561

5 in total